Monoclonal Antibody Manufacturing For Biopharma Should I Build Or Outsource
Monoclonal Antibody Manufacturing For Biopharma: Should I Build Or Outsource? By Dan Slone, Head of DS Manufacturing A company’s strategy is crucial for determining future success, and therefore, it needs to constantly change in line with market dynamics. According to Coherent Market Insights, the global biologics market held an estimated value of $255.19 billion in 2019 and is expected to exhibit a CAGR of 7.6% between 2019 and 2027. 1 Market indicators for monoclonal antibodies (mAbs) appear even stronger, with an estimated market value of $143.5 billion in 2020 and 14.4% CAGR expected ov...
Source: pharmaceuticalonline.com